Ardent Health Partners (ARDT) Projected to Post Earnings on Tuesday

Ardent Health Partners (NYSE:ARDT - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data after the market closes on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.27 per share and revenue of $1.50 billion for the quarter. Ardent Health Partners has set its FY 2025 guidance at 1.730-2.010 EPS.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. On average, analysts expect Ardent Health Partners to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Partners Trading Up 0.9 %

Shares of NYSE:ARDT traded up $0.11 during trading on Tuesday, hitting $12.65. The company had a trading volume of 29,276 shares, compared to its average volume of 435,484. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company has a fifty day simple moving average of $13.30 and a two-hundred day simple moving average of $15.29. Ardent Health Partners has a one year low of $11.31 and a one year high of $20.72.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ARDT shares. Stephens reaffirmed an "overweight" rating and set a $22.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Guggenheim assumed coverage on shares of Ardent Health Partners in a research report on Wednesday, April 9th. They issued a "buy" rating and a $16.00 price objective on the stock. Truist Financial decreased their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Mizuho reduced their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, Morgan Stanley dropped their price objective on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $20.58.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.